ROR has also been involved in breast cancer resistance to 5-FU and paclitaxel, while it could inflame EMT and metastasis in both breast and pancreatic tumors, via different mechanisms, including, among others, Snail and ZEB1 activation, through p53 inhibition [115,116,117,118,119,120]. This evidence concerns the gene ZEB1 and breast carcinoma.